SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Interim Management Statement

31 Oct 2014 07:00

ELEMENTIS PLC - Interim Management Statement

ELEMENTIS PLC - Interim Management Statement

PR Newswire

London, October 30

Elementis - Interim Management Statement Elementis plc (ELM.L, "Elementis" or the "Group"), the Global SpecialtyChemicals Company, today issues its Interim Management Statement for the threemonths ended 30 September 2014. Commenting on the Group's performance Group Chief Executive, David Dutro, said: "Elementis is pleased to report another resilient performance that furtherdemonstrates our ability to deliver profitable growth in an economicenvironment that continues to be challenging. Our recent investments in newproducts and geographies combined with our strong market positions and customerrelationships mean that we have a broad base of growth opportunities. Togetherwith our ability to generate significant positive cash flow this provides anattractive platform from which to deliver sustainable value to ourshareholders." Specialty Products' sales improved by 6 per cent in both dollars and volumescompared to the same period last year. * In coatings, sales improved by 6 per cent as the business continued to benefit from its broad geographic base and recent investments in growth. North America sales improved by 5 per cent, helped by growing sales from the new decorative additives plant in New Martinsville and defoamer sales from the Hi-Mar acquisition. In Europe, sales were 11 per cent higher, or 8 per cent excluding currency, as the business team there supplemented the subdued underlying growth in Western Europe with sales of new products, as well as additional sales into Eastern Europe and the Middle East. Asia Pacific sales increased by 4 per cent and Latin America sales were similar to the previous quarter as good progress in delivering synergy benefits from the Watercryl acquisition was offset by soft underlying demand due to weak economic activity. * In personal care, sales for the quarter improved by 6 per cent, bringing the sales growth for the first nine months of the year to 16 per cent, as new products and sales into emerging markets continued to drive performance. * Sales to oil and gas drilling improved by 6 per cent as the business returned to more normal operating rates following the slower start to the year. * Operating margin in the quarter was slightly below the same period last year due to the impact of the start-up phase of the recently completed New Martinsville plant, where production activity is building in line with management expectations. Overall pricing and contribution margins across the businesses remained relatively stable. Chromium continued to perform in line with its strategy of delivering stableearnings and cash flow, with sales in the third quarter 2 per cent higher andoperating profit at a similar level to the previous period. The business hascontinued to experience solid demand in its key North American market andrecent improvements in leather tanning activity, which has been relatively softover the last two years, helped increase the percentage of sales to the regionto 68 per cent, compared to 63 per cent in the first six months of the year.Operational efficiencies continue to contribute to the overall stability andperformance of Chromium. The next planned maintenance shutdown is scheduled totake place during the first half of 2015. Strong cash flow continues to be a positive aspect of the Group's performanceand it is anticipated that the end of year balance sheet will show a net cashbalance of at least $40 million. Overall we remain confident in the Group's ability to deliver growth in excessof the underlying economies in which we operate and expect our full yearearnings per share to be in line with market expectations. END Enquiries Elementis plc Tel: +44 (0) 20 7408 9300Brian Taylorson, Finance Director FTI Consulting Tel: +44 (0) 20 3727 1000Deborah ScottMatthew Cole
Date   Source Headline
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration
9th Mar 20232:50 pmRNSDirector/PDMR Shareholding
9th Mar 20232:47 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSPreliminary results year ended 31 December 2022
1st Mar 20239:53 amRNSBlock listing Interim Review
1st Mar 20239:39 amRNSTotal Voting Rights
31st Jan 20233:04 pmRNSSale of Chromium business
19th Jan 20237:00 amRNSTrading Update
3rd Jan 20239:47 amRNSTotal Voting Rights
8th Dec 20222:10 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSSale of Chromium business
23rd Nov 20223:54 pmRNSHolding(s) in Company
16th Nov 20221:43 pmRNSHolding(s) in Company
10th Nov 20229:40 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSDirectorate Change
1st Nov 20229:48 amRNSTotal Voting Rights
31st Oct 20223:23 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSQ3 Trading Update
18th Oct 20223:13 pmRNSHolding(s) in Company
3rd Oct 20229:39 amRNSTotal Voting Rights
29th Sep 202212:45 pmRNSDirector/PDMR Shareholding
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
22nd Sep 202211:17 amRNSDirector/PDMR Shareholding
21st Sep 20224:58 pmRNSDirector/PDMR Shareholding
21st Sep 20223:48 pmRNSDirector/PDMR Shareholding
6th Sep 202212:52 pmRNSDirector Declaration
5th Sep 20224:14 pmRNSAdditional Listing
1st Sep 202212:39 pmRNSHolding(s) in Company
1st Sep 20229:15 amRNSBlock listing Interim Review
1st Sep 20229:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.